In addition, elevation of PLK1 attenuates the expression of class II major histocompatibility complex (MHC-II) in professional antigen presentation cells and cancer cells, leading to impaired antigen presentation and anti-tumor immunity. This evidence concerns the gene PLK1 and cancer.